三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
开坦尼®(卡度尼利,PD-1/CTLA-4)临床研究计划
开坦尼®(卡度尼利,PD-1/CTLA-4)临床研究计划
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:1333KB
图片尺寸:2303*938
同报告图片
/
4
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
fCDnlr7nl4UgICAgICAgICB8IOaVsOmHjyB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS18Cnwg6Z2e5bCP57uG6IOe6IK655mMIHwgODcgICB8Cnwg5a6e5L2T55ikICAgICAgIHwgODAgICB8Cnwg6buR6Imy57Sg55ikICAgICB8IDU1ICAgfAp8IOWktOmiiOmDqOmznueKtue7huiDnueZjCB8IDUxICAgfAp8IOS4iemYtOaAp+S5s+iFuueZjCB8IDM3ICAgfAp8IOe7k+ebtOiCoOeZjCAgICAgfCAzNCAgIHwKfCDljbXlt6LnmYwgICAgICAgfCAzMyAgIHwKfCDog4PnmYwgICAgICAgICB8IDI1ICAgfAp8IOS5s+iFuueZjCAgICAgICB8IDIzICAgfAp8IOiCvue7huiDnueZjCAgICAgfCAyMyAgIHwKfCDlhbbku5YgICAgICAgICB8IDI0NSAgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Y2O56aP6K+B5Yi456CU56m25omA77yI5oiq6IezIDIwMjQg5bm0IDYg5pyIIDI1IOaXpe+8iQ==
fCDliIbmnJ8gfCDmlbDph48gfAp8IC0tLSB8IC0tLSB8CnwgSUlJ5pyfIHwgOTIgfAp8IEkvSUnmnJ8gfCA4NiB8CnwgSUnmnJ8gfCAyOTYgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Y2O56aP6K+B5Yi456CU56m25omA77yI5oiq6IezMjAyNOW5tDbmnIgyNeaXpe+8iQ==
所属报告:
康方生物-港股公司研究报告-肺癌大适应症先发优势占位IO 2.0的未来已来-240708(31页).pdf
打包全文图表
相关数据
国内CTLA4相关标的、相关管线
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+6I2v54mp5ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPueglOWPkeS8geS4mjwvdGg+CiAgICAgICAgICAgIDx0aD7liIblrZDorr7orqHnibnngrk8L3RoPgogICAgICAgICAgICA8dGg+5pyA6auY56CU5Y+R6Zi25q6177yI5oiq6IezMjAyNeW5tDEy5pyI77yJPC90aD4KICAgICAgICAgICAgPHRoPuacuuWItuivtOaYjjwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+SEJNNDAwMzwvdGQ+CiAgICAgICAgICAgIDx0ZD7lkozpk4LljLvoja88L3RkPgogICAgICAgICAgICA8dGQ+5YWo5Lq65rqQ6YeN6ZO+5oqX5L2T77yM57uPRmPmrrXlt6XnqIvljJbmlLnpgKA8L3RkPgogICAgICAgICAgICA8dGQ+4oWh5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPkZj5q6157uP6L+H5pS56YCg77yM5pi+6JGX5aKe5by6QURDQ+a0u+aAp++8jOaXqOWcqOmrmOaViOa4hemZpOiCv+eYpOW+rueOr+Wig+S4reeahFRyZWfnu4bog548L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+QURHMTI2KE11emFzdG90dWcpPC90ZD4KICAgICAgICAgICAgPHRkPuWkqea8lOiNr+S4mjwvdGQ+CiAgICAgICAgICAgIDx0ZD7mjqnolL3lnovmipdDVExBIC0gNOWuieWFqOaKl+S9kyhTQUZFYm9kecKuKTwvdGQ+CiAgICAgICAgICAgIDx0ZD7ihaHmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+5YW25rS75oCn5b2i5byPKOWOu+aOqeiUveWQjinpgJrov4fpnbblkJHni6znibnmipfljp/ooajkvY3lkozlop7lvLrnmoRBREND5pWI5bqU5p2l5riF6ZmkVHJlZ+e7huiDnjwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5JTU0yN00o5rOw5rO96IuP5ouc5Y2V5oqX77yMVGF6bGVzdG9iYXJ0KTwvdGQ+CiAgICAgICAgICAgIDx0ZD7lrpzmmI7mmILnp5E8L3RkPgogICAgICAgICAgICA8dGQ+QURDQ+WinuW8uuWei0lnRzHljZXmipfvvIzpgJrov4fln7rlm6Dlt6XnqIvmlLnpgKDliqDlvLpBREND5rS75oCnPC90ZD4KICAgICAgICAgICAgPHRkPuS4tOW6ikliL+KFoOacnzwvdGQ+CiAgICAgICAgICAgIDx0ZD7orr7orqHmoLjlv4PmmK/pgJrov4flop7lvLrnmoRBREND5pWI5bqU77yM5LyY5YWI5riF6Zmk6IK/55ik5b6u546v5aKD5Lit55qEVHJlZ+e7huiDnu+8jOaXqOWcqOiOt+W+l+abtOW8uuaKl+iCv+eYpOa0u+aAp+WSjOabtOWlveWuieWFqOaApzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5MTSAtIDE2ODwvdGQ+CiAgICAgICAgICAgIDx0ZD7npLzmlrDljLvoja88L3RkPgogICAgICAgICAgICA8dGQ+6IK/55ik5b6u546v5aKD6YCJ5oup5oCnQ1RMQSAtIDTljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+SS/ihaHmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+5peo5Zyo5p2h5Lu25oCn6Z225ZCR6IK/55ik5b6u546v5aKD77yM5biM5pyb5YCf5q2k5Zyo5L+d5oyB55aX5pWI55qE5ZCM5pe26ZmN5L2O5YWo6Lqr5q+S5oCnPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPkFLMTA0KOWNoeW6puWwvOWIqeWNleaKlyk8L3RkPgogICAgICAgICAgICA8dGQ+5bq35pa555Sf54mpPC90ZD4KICAgICAgICAgICAgPHRkPlBEIC0gMS9DVExBIC0gNOWPjOeJueW8guaAp+aKl+S9kzwvdGQ+CiAgICAgICAgICAgIDx0ZD7lt7LkuIrluIIo55So5LqO5a6r6aKI55mM562JKTwvdGQ+CiAgICAgICAgICAgIDx0ZD7kvZzkuLrlj4zmipfvvIzlhbZDVExBIC0gNOmdtuWQkeerr+eahOiuvuiuoeS/neeVmeS6hkZj5Yqf6IO977yM5Y+v6YCa6L+HQURDQ+aViOW6lOa4hemZpFRyZWfnu4bog548L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+Q1MyMDA5PC90ZD4KICAgICAgICAgICAgPHRkPuWfuuefs+iNr+S4mjwvdGQ+CiAgICAgICAgICAgIDx0ZD5QRCAtIDEvVkVHRi9DVExBIC0gNOS4ieeJueW8guaAp+aKl+S9kzwvdGQ+CiAgICAgICAgICAgIDx0ZD7ihaHmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+5ZCM5pe26Zi75pat5LiJ5Liq5YWz6ZSu5L+h5Y+36YCa6Lev77yM5peo5Zyo5a6e546w5Y2P5ZCM5aKe5pWI44CC5YW26K6+6K6h6IO95LyY5YWI57uT5ZCI6IK/55ik5b6u546v5aKD5Lit55qE5Y+M6Ziz5oCnVOe7huiDnu+8jOW5tuWHreWAn0NUTEEgLSA06IeC55qE5L2O5Lqy5ZKM5Yqb77yM5Y+v6IO95pyJ5Yqp5LqO6ZmN5L2O5aSW5ZGo5q+S5oCnPC90ZD4KICAgICAgICA8L3RyPgogICAgPC90Ym9keT4KPC90YWJsZT4KCui1hOaWmeadpea6kO+8muWQhOWFrOWPuOWumOe9ke+8jOS4gemmmeWbre+8jOWMu+iNr+ingua+nO+8jOS4reazsOivgeWIuOeglOeptuaJgApgYGA=
收藏
行业数据
2025-12-24
原图定位
查看详情
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)
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
收藏
行业数据
2025-12-24
原图定位
查看详情
2019-2035E全球CTLA-4抗体药物市场(亿美元)
fCDlubTku70gICB8IOS4reWbve+8iOS6v+e+juWFg++8iSB8IOWFqOeQg+WFtuS7luWcsOWMuu+8iOS6v+e+juWFg++8iSB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTkgICB8IDEgICAgICAgICAgICAgIHwgMTUgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIwICAgfCAxICAgICAgICAgICAgICB8IDE4ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMSAgIHwgMSAgICAgICAgICAgICAgfCAyMCAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjIgICB8IDEgICAgICAgICAgICAgIHwgMjIgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIzICAgfCAyICAgICAgICAgICAgICB8IDI2ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNCAgIHwgMyAgICAgICAgICAgICAgfCAzMiAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjVFICB8IDMgICAgICAgICAgICAgIHwgMzcgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI2RSAgfCA0ICAgICAgICAgICAgICB8IDM4ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyN0UgIHwgNSAgICAgICAgICAgICAgfCA0NSAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjhFICB8IDYgICAgICAgICAgICAgIHwgNjUgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI5RSAgfCA3ICAgICAgICAgICAgICB8IDkzICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAzMEUgIHwgOCAgICAgICAgICAgICAgfCAxMjIgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMzFFICB8IDEwICAgICAgICAgICAgIHwgMTQwICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDMyRSAgfCAxMiAgICAgICAgICAgICB8IDE2MCAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAzM0UgIHwgMTQgICAgICAgICAgICAgfCAxODAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMzRFICB8IDE2ICAgICAgICAgICAgIHwgMjAwICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDM1RSAgfCAxOCAgICAgICAgICAgICB8IDIyNSAgICAgICAgICAgICAgICAgICAgICB8CgrmlbDmja7mnaXmupDvvJrmi5vogqHor7TmmI7kuabjgIHlvJfoi6Xmlq/nibnmspnliKnmlofjgIHlm73mipXor4HliLjlm73pmYU=
收藏
行业数据
2025-12-22
原图定位
查看详情
全球(中国除外)CTLA-4靶向双抗/双功能融合蛋白管线竞争格局(截至2025
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
收藏
竞争格局
2025-12-22
原图定位
查看详情
2019-2035E全球CTLA-4抗体药物市场(亿美元)
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
收藏
行业数据
2025-12-19
原图定位
查看详情
全球(中国除外)CTLA-4靶向双抗/双功能融合蛋白管线竞争格局(截至2025
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+6Z2254K5PC90aD4KICAgICAgICAgICAgPHRoPuS6p+WTgTwvdGg+CiAgICAgICAgICAgIDx0aD7lhazlj7g8L3RoPgogICAgICAgICAgICA8dGg+6YCC5bqU55eHPC90aD4KICAgICAgICAgICAgPHRoPuS4tOW6iumYtuautTwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+Q1RMQTTjgIFDRDQ3PC90ZD4KICAgICAgICAgICAgPHRkPkhYMDQ0PC90ZD4KICAgICAgICAgICAgPHRkPue/sOaAneeUn+eJqTwvdGQ+CiAgICAgICAgICAgIDx0ZD7mmZrmnJ/lrp7kvZPnmKTmgbbmgKfogr/nmKQ8L3RkPgogICAgICAgICAgICA8dGQ+SS9JSWHmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQgcm93c3Bhbj0iMyI+Q1RMQTTjgIFQRCAtIDE8L3RkPgogICAgICAgICAgICA8dGQgcm93c3Bhbj0iMyI+Vm9scnVzdG9taW5nL01FRDE1NzUyPC90ZD4KICAgICAgICAgICAgPHRkIHJvd3NwYW49IjMiPumYv+aWr+WIqeW6tzwvdGQ+CiAgICAgICAgICAgIDx0ZD5OU0NMQ+OAgeWxgOmDqOaZmuacn+Wuq+miiOeZjOOAgeS4jeWPr+WIh+mZpOeahOiDuOiGnOmXtOearueYpOOAgUhOU0ND44CB5pma5pyf6IK+6YCP5piO57uG6IOe55mMPC90ZD4KICAgICAgICAgICAgPHRkPklJSeacnzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5IQ0PjgIFCVEPjgIHmmZrmnJ/lrp7kvZPnmKTjgIHovaznp7vmgKfnu5Pnm7TogqDnmYzjgIHlsYDpg6jmmZrmnJ/kuI3lj6/liIfpmaTmiJbovaznp7vmgKfog4PnmYzmiJbog4Ppo5/nrqHkuqTnlYzohbrnmYw8L3RkPgogICAgICAgICAgICA8dGQ+SUnmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+UkND44CB6L2v57uE57uH6IKJ55ikPC90ZD4KICAgICAgICAgICAgPHRkPknmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICA8L3Rib2R5Pgo8L3RhYmxlPgoK5pWw5o2u5p2l5rqQ77ya5oub6IKh6K+05piO5Lmm44CB6I2v5a6h5Lit5b+D44CB5paH54yu57u86L+w44CB5byX6Iul5pav54m55rKZ5Yip5paH44CB5Zu95oqV6K+B5Yi45Zu96ZmFCmBgYA==
收藏
竞争格局
2025-12-19
原图定位
查看详情
阿布昔替尼的应答率及应答时间优于度普利尤单抗
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
收藏
行业数据
2024-12-12
原图定位
查看详情
度普利尤单抗与乌帕替尼、阿布西替尼安全性数据对比
fCDkuLTluornoJTnqbYgfCDoja/lk4EgICAgICAgfCDoja/nianliYLph48gICB8IOS4jeiJr+S6i+S7tiUgfCDkuKXph43kuI3oia/kuovku7YlIHwg5LiN6Imv5LqL5Lu26Ie05YGc6I2vJSB8IOatu+S6oSUgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tfAp8IEhlYWRzIFVwIHwg5bqm5pmu5Yip5bCk5Y2V5oqXIHwgMzAwbWcgcTJ3ICB8IDYyLjgwJSAgICB8IDEuMjAlICAgICAgICAgfCAxLjIwJSAgICAgICAgICAgfCAwLjAwJSB8CnwgICAgICAgICAgfCDkuYzluJXmm7/lsLwgICAgfCAzMG1nIHFkICAgIHwgNzEuNjAlICAgIHwgMi45MCUgICAgICAgICB8IDIuMDAlICAgICAgICAgICB8IDAuMzAlIHwKfCBDT01QQVJFICB8IOW6puaZruWIqeWwpOWNleaKlyB8IDMwMG1nIHEydyAgfCA1MC4wMCUgICAgfCAwLjgwJSAgICAgICAgIHwgMy4zMCUgICAgICAgICAgIHwgMC4wMCUgfAp8ICAgICAgICAgIHwg6Zi/5biD6KW/5pu/5bC8ICB8IDEwMG1nIHFkICAgfCA1MC44MCUgICAgfCAyLjUwJSAgICAgICAgIHwgMi41MCUgICAgICAgICAgIHwgMC4wMCUgfAp8ICAgICAgICAgIHwgICAgICAgICAgICB8IDIwMG1nIHFkICAgfCA2MS45MCUgICAgfCAwLjkwJSAgICAgICAgIHwgNC40MCUgICAgICAgICAgIHwgMC4wMCUgfAoK6LWE5paZ5p2l5rqQ77yaSkFNQSBEZXJtYXRvbG9neSwgTkVKTSwg5bm/5Y+R6K+B5Yi45Y+R5bGV56CU56m25Lit5b+D
收藏
行业数据
2024-12-05
原图定位
查看详情
2022H2-2023H2卡度尼利单抗销售额(亿元)
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
收藏
行业数据
2024-10-21
原图定位
查看详情
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗在全人群优于贝伐和化疗
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗与纳武利尤单抗联合伊匹木单抗相比安全性更优
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗肝癌销售峰值有望超20亿元
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗胃癌销售峰值有望超20亿元
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
收藏
其它
2024-07-10
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
公司首次覆盖 | 康方生物卡度尼利单抗目前 6项 III期关键性临床同步进行中,包括胃癌、肺癌、宫颈癌
其它
原图定位
当前图表所属:
康方生物-港股公司研究报告-肺癌大适应症先发优势占位IO 2.0的未来已来-240708(31页).pdf
PD-1/PD-L1抑制剂开发联合化疗、靶向疗法以及其他免疫疗法
默沙东在ADC领域的交易汇总
K药正在进行中的全球临床管线(按疾病)
K药正在进行中的全球临床管线(按分期)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》